The largest database of trusted experimental protocols

Cd16 monocyte isolation kit

Manufactured by Miltenyi Biotec

The CD16+ Monocyte Isolation Kit is a laboratory product designed to isolate CD16+ monocytes from human peripheral blood mononuclear cells. It utilizes magnetic separation technology to selectively enrich for the target cell population.

Automatically generated - may contain errors

8 protocols using cd16 monocyte isolation kit

1

Isolation of Monocyte Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
The experiments conform to the principles set out in the WMA Declaration of Helsinki and the Department of Health and Human Services Belmont Report and were approved by the local ethics board. Human CD14++CD16neg and CD14+CD16++ monocytes were isolated from blood rings of healthy donors after written consent (Blood bank, Medizinische Hochschule Hannover) using CD14 microbeads and CD16 monocyte isolation kit (Miltenyi Biotec), respectively, according to manufacturer's instructions. The purity of the isolated cells was more than 90% routinely tested by flow cytometry. Human aortic endothelial cells (HAEC) were purchased from Lonza and cultured as per manufacturer's instructions.
+ Open protocol
+ Expand
2

Isolation of CX3CR1-expressing CD16+ Monocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human primary monocytes (5 × 106/mL) were cultured in 5 mL RPMI medium containing 2% FCS in teflon coated bags [56 (link)] in the presence or the absence of recombinant human CX3CL1 (50 ng/mL, Biolegend) at 37 °C and 10% CO2. After 18 h of culturing, monocytes were collected and subjected to isolation of CD16+ monocytes, using the CD16+ Monocyte Isolation Kit (Miltenyi Biotec), according to the manufacturer’s manual. The primary monocytes were subjected to a two-step procedure. First, cells were labeled with a non-monocyte depletion cocktail, for labeling and removing CD15+ granulocytes and CD56+ natural killer cells. Thereafter, the flow through fraction was labeled with CD16+ magnetic microbeads for positive selection of CD16+ monocytes. CD16 positive selection was performed to enrich CD16+ monocytes, described to express the CX3CL1-receptor CX3CR1 [23 (link),24 (link)]. CX3CR1 expression in CD16+ monocytes was confirmed by qPCR (Figure S3).
+ Open protocol
+ Expand
3

Purification of Human Monocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human monocytes were isolated from the blood of healthy individuals as approved by the ethical committee of Hannover Medical School. Written consent was obtained before blood collection. Cells were purified using CD16+ monocyte isolation kit (Miltenyi Biotec) according to the manufacturer's instruction. CD14+ monocytes were retrieved in subsequent purification step from CD16neg fraction using CD14 microbeads.
+ Open protocol
+ Expand
4

Isolation and Cryopreservation of Peripheral Blood Mononuclear Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral Blood Mononuclear Cells (PBMCs) were immediately isolated by density centrifugation using pre-filled Greiner Bio-One Leucosep® tubes according to the manufacturer’s recommendations. PBMCs rings were collected and washed twice in PBS before final suspension at 20 × 106 cells/ml in ice-cold freezing medium (50% RPMI-1640, 40% fetal bovine serum, 10% DMSO) and transferred at −80°C in Nalgene® Mr. Frosty for short-term storage (<1 month). For monocyte isolation, 40 × 106 to 60 × 106 cells of cryopreserved PBMCs were thawed and quickly washed with 13 ml ice-cold RPMI-1640. Median cell viability upon recovery was assessed by trypan blue exclusion (88.37%, IQR: 82.1-97). Pan- and CD16+ monocyte purification were performed using Pan Monocyte Isolation Kit and CD16+ Monocyte Isolation Kit respectively according to manufacturer’s instructions (Miltenyi Biotec GmbH).
+ Open protocol
+ Expand
5

Purification of Monocyte Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were separated by Ficoll (GE Healthcare, Port Washington, NY) density gradient centrifugation and subjected to cell subset purification by magnetic bead purification (all from Miltenyi Biotec, Auburn, CA). CD4+ T cells and total monocytes were purified using CD4+ T cell isolation kit and CD14 microbeads, respectively (purity>95% for both) following manufacturer’s instructions. For purification of CD16+ and CD16 monocyte subsets, the CD16+ monocyte isolation kit (Miltenyi Biotec) was used first to purify CD16+ monocytes by positive selection (purity>95%) and the negatively selected fraction was then incubated with CD14 microbeads to obtain the CD14+CD16 cell population (purity>95%) following manufacturer’s instructions.
+ Open protocol
+ Expand
6

CFSE Labeling of CD16+ Monocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells were separated over Ficoll-Paque as above and the CD16+ monocytes were then magnetically isolated using a CD16+ monocyte isolation kit (Miltenyi Biotec) according to manufacturer's instructions. CD16+ monocytes were then washed in phosphate buffered solution (PBS) and incubated in PBS containing 2.5 μM Carboxyfluorescein succinimidyl ester (CFSE [Biolegend]) for 20 min at 37°C. Cells were then washed in RPMI 1640 containing penicillin/streptomycin, L-glutamine and 10% HI-FCS and added back into non-labeled PBMCs from the same donor. PBMCs were then seeded in 12 well plates in complete RPMI and incubated with or without 20 ng/mL LPS for 3 h prior to identification by flow cytometry, as above.
+ Open protocol
+ Expand
7

Purification and Isolation of Platelets and Monocytes from RA Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
The study protocols were approved by the institutional review board (IRB) of Seoul National University Hospital and Chungnam National University Hospital. Peripheral blood of RA patients and healthy controls (HCs) was drawn after obtaining written, informed consent. The methods were performed in accordance with the approved guidelines. The patient characteristics of RA patients enrolled in this study are summarized in Table 1. To obtain platelets, platelet-rich plasma (PRP) was prepared from whole blood by centrifugation at 190 g for 15 min at room temperature (RT). Subsequently, platelet pellet was prepared from PRP by centrifugation at 2,400 g for 5 min and was resuspended with 25mM HEPES-buffered Tyrode’s solution (Sigma-Aldrich, St. Louis, MO). Peripheral blood mononuclear cells (PBMC) were isolated from blood by density gradient centrifugation (Bicoll separating solution; BIOCHROM Inc., Cambridge, UK). To purify CD14+CD16- monocytes, CD16+ monocytes were negatively depleted from PBMC with CD16+ Monocyte Isolation Kit (Miltenyi Biotec Inc., Auburn, CA) and CD14+ monocytes were positively purified from CD16+ cell-depleted PBMC using anti-CD14 microbeads (Miltenyi Biotec Inc.).
+ Open protocol
+ Expand
8

Isolation of Monocyte Subsets from Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells were isolated from buffy coats obtained from the National University Hospital Blood Transfusion Services, Singapore. Informed written consent was given in accordance to the declaration of Helsinki. All blood samples and procedures were approved by the NHG Domain Specific Review Board, Singapore (Reference code 08-352E). Following Ficoll-Hypaque density gradient centrifugation of the buffy coat, CD16 À and CD16 + monocyte subsets were isolated using the CD16 Monocyte Isolation Kit (Miltenyi Biotec) according to the manufacturer's instructions, with some modifications. Briefly, after magnetic depletion of natural killer cells, granulocytes, B cells and T cells using anti-CD56, anti-CD15, anti-CD3 and anti-CD19 microbeads, the CD16 + monocytes were positively selected using anti-CD16 microbeads. The CD16 À monocytes were then isolated from the negative fraction with anti-CD14 microbeads. Purity of the monocyte subsets obtained was assessed by flow cytometry with fluorochrome-conjugated anti-CD14 and anti-CD16 antibodies and was consistently ≥ 95% (see Supporting information, Fig. S1). The percentage of dead cells in the isolated subsets was always < 5%.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!